Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial-Reference-Cited by-同舟云学术

Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial

Published:2016-10-17 Issue:4 Volume:17 Page:1020-1030
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Bemelman F. J.¹,de Fijter J. W.²,Kers J.³,Meyer C.⁴,Peters-Sengers H.¹,de Maar E. F.⁵,van der Pant K. A. M. I.¹,de Vries A. P. J.²,Sanders J.-S.⁵,Zwinderman A.⁶,Idu M. M.⁷,Berger S.⁵,Reinders M. E. J.²,Krikke C.⁸,Bajema I. M.⁹,van Dijk M. C.¹⁰,ten Berge I. J. M.¹,Ringers J.¹¹,Lardy J.¹²,Roelen D.¹³,Moes D.-J.¹⁴,Florquin S.³,Homan van der Heide J. J.⁵

Affiliation:

1. Renal Transplant Unit; Amsterdam the Netherlands

2. Renal Transplant Unit; Department of Nephrology; Leiden University Medical Centre; Leiden the Netherlands

3. Department of Pathology; Academic Medical Centre; Amsterdam the Netherlands

4. University of Amsterdam; Amsterdam the Netherlands

5. Department of Nephrology; Groningen University Hospital; Groningen the Netherlands

6. Department of Epidemiology and Biostatistics; Academic Medical Centre; Amsterdam the Netherlands

7. Department of Surgery; Academic Medical Centre; Amsterdam the Netherlands

8. Department of Surgery; Groningen University Hospital; Groningen the Netherlands

9. Department of Pathology; Leiden University Medical Centre; Leiden the Netherlands

10. Department of Pathology; Groningen University Hospital; Groningen the Netherlands

11. Department of Surgery; Leiden University Medical Centre; Leiden the Netherlands

12. Sanquin Diagnostic Services; Amsterdam the Netherlands

13. Department of Immunogenetics and Transplantation Immunology; Leiden University Medical Centre; Leiden the Netherlands

14. Department of Clinical Pharmacy and Toxicology; Leiden University Medical Centre; Leiden the Netherlands

Funder

Novartis Pharma

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14048/fullpdf

Reference32 articles.

1. Immunosuppressive drugs in kidney transplantation: Impact on patient survival, and incidence of cardiovascular disease, malignancy and infection;Marcen;Drugs,2009

2. Calcineurin inhibitor minimization in the Symphony study: Observational results 3 years after transplantation;Ekberg;Am J Transplant,2009

3. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study;Ekberg;Am J Transplant,2007

4. Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: A randomized, multicenter, 24-month study;Holdaas;Transplantation,2011

5. Calcineurin inhibitor nephrotoxicity;Naesens;Clin J Am Soc Nephrol,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse cognitive effects of glucocorticoids: A systematic review of the literature;Steroids;2023-12

2. Mycophenolic Acid Exposure Determines Antibody Formation Following SARS‐CoV‐2 Vaccination in Kidney Transplant Recipients: A Nested Cohort Study;Clinical Pharmacology & Therapeutics;2023-03-14

3. Recommendations for living donor kidney transplantation;Nefrología (English Edition);2022-12

4. Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-08

5. The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation;PLOS ONE;2022-04-21